Promise and Implementation of Proteomic Prostate Cancer Biomarkers

Prostate cancer is one of the most commonly diagnosed malignancy and the fifth leading cause of cancer mortality in men. Despite the broad use of prostate-specific antigen test that resulted in an increase in number of diagnosed cases, disease management needs to be improved. Proteomic biomarkers al...

Descripción completa

Detalles Bibliográficos
Autores principales: Latosinska, Agnieszka, Frantzi, Maria, Merseburger, Axel S., Mischak, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174350/
https://www.ncbi.nlm.nih.gov/pubmed/30158500
http://dx.doi.org/10.3390/diagnostics8030057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174350/
https://www.ncbi.nlm.nih.gov/pubmed/30158500
http://dx.doi.org/10.3390/diagnostics8030057

Ejemplares similares